Cooper Companies | COO - Ebitda

Preço das Ações
64.42
Mudança Diária
-0.53 -0.82%
Mensal
-9.84%
Anual
-20.36%
Q2 Previsão
63.04




Ebitda Alterar Data
Abbott USD 3.27B 178M 2025-12
Align Technology USD 183.84M 19.77M 2025-09
AtriCure USD 19.86M 2.06M 2025-12
Avanos Medical USD 10M 73.9M 2025-09
Bausch Health Companies USD 986M 74M 2025-09
Baxter International USD 426M 36M 2025-09
Bayer EUR 1.97B 457M 2025-12
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.16B 213M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
Dentsply International USD 135M 32M 2025-12
Dexcom USD 422.2M 53.8M 2025-12
Edwards Lifesciences USD 70.1M 394.2M 2025-12
Globus Medical USD 280.46M 27.86M 2025-12
Haemonetics USD 115.53M 9.22M 2025-09
Insulet USD 194M 34M 2025-12
Integra LifeSciences USD 104.21M 25.76M 2025-12
Intuitive Surgical USD 1.09B 165.5M 2025-12
J&J USD 7.19B 2.32B 2025-12
Medtronic USD 2.93B 482M 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Novartis USD 5.84B 235M 2025-09
ResMed USD 547.48M 27.46M 2025-12
STAAR Surgical USD -159K 34.78M 2025-12
Steris USD 389.7M 22.5M 2025-09
Stryker USD 1.67B 206M 2025-09
Tandem Diabetes Care USD 32.9M 30.13M 2025-12
Teleflex USD -328.81M 536.43M 2025-09
Zimmer Biomet Holdings USD 759M 120.8M 2025-12